Connecting Innovators with Industry
< >
Advancing a Promising Anti-cancer Agent
Total synthesis of halichondrin enables Phase I clinical trial
Collaboration with Eisai
Harvard chemists have achieved what a new paper calls a “landmark in drug discovery” XNew License in CRISPR Human Therapeutics
Verve Therapeutics aims to develop therapies to protect against heart disease in adults
Toward Novel Cell Therapies
Immune-silent stem cell technology licensed to Sana Biotechnology
